Cystoscopy Patient Preparation Guidelines
For simple diagnostic outpatient cystoscopy in healthy adults with sterile urine, antibiotic prophylaxis is not recommended, and the procedure can be performed under local anesthesia using a flexible cystoscope. 1
Pre-Procedure Assessment
Patient Risk Stratification
Determine infection risk before deciding on prophylaxis:
- Low-risk patients (healthy adults with sterile urine undergoing simple diagnostic cystoscopy): No antibiotic prophylaxis needed 1
- High-risk patients requiring prophylaxis include:
Urine Testing Requirements
Pre-procedure urinalysis should be obtained, but a positive dipstick alone in asymptomatic patients is not a contraindication to proceeding: 3
- Urine culture is only necessary if the patient has symptoms of UTI or falls into high-risk categories 2
- Do not routinely cancel cystoscopy based solely on positive urinalysis (leucocyte esterase/nitrites) if the patient is asymptomatic - this causes unnecessary delays without improving safety 3
- The risk of post-procedure UTI remains low (6.8%) even with positive pre-procedure urinalysis, with no cases of sepsis reported 3
Antibiotic Prophylaxis Decision Algorithm
For patients requiring prophylaxis, administer a single dose within one hour before the procedure: 1
- First-line options: First- or second-generation cephalosporins, trimethoprim-sulfamethoxazole 1
- Alternatives: Amoxicillin/clavulanate or aminoglycoside-ampicillin combination 1
- Route: Single oral dose is sufficient for most cases 1
Important caveat: Recent high-quality evidence shows that in patients with sterile urine undergoing diagnostic cystoscopy, antibiotic prophylaxis does not significantly reduce UTI rates (risk difference -0.009,95% CI -0.03 to 0.011) 4. However, prophylaxis remains indicated for the high-risk groups listed above 1.
Equipment and Anesthesia Selection
Flexible cystoscopy under local anesthesia is preferred over rigid cystoscopy for initial diagnostic procedures: 1
- Advantages of flexible cystoscopy:
Required equipment: Flexible cystoscope, irrigant, lubricating gel, sterile gloves, and towels/drapes 6
Patient Positioning
Special Populations Requiring Additional Monitoring
Neurogenic Bladder Patients at Risk for Autonomic Dysreflexia
Patients with spinal cord injury at T6 or above require continuous hemodynamic monitoring during cystoscopy: 1
- Have pharmacotherapy for autonomic dysreflexia readily available before starting 1
- If autonomic dysreflexia develops: Immediately terminate the procedure, drain the bladder, and continue monitoring 1
- If symptoms persist after bladder drainage (systolic BP >150 mmHg or >20 mmHg above baseline with symptoms): Initiate pharmacologic management and escalate care 1
High-Risk Patients for Bladder Cancer
Cystoscopy timing based on cancer risk stratification (post-TURBT surveillance): 1
- Low-risk tumors: First cystoscopy at 3 months, then at 12 months, then annually for years 2-5 1
- Intermediate-risk tumors: Cystoscopy with urine cytology at 3,6,9,12,18, and 24 months, then annually for years 3-5 1
- High-risk tumors: Cystoscopy with urine cytology every 3 months for 2 years, then every 6 months for years 3-5, then annually after year 6 1
Technical Considerations
For surveillance cystoscopy in bladder cancer patients, integrated dual-channel bladder catheters are recommended to prevent infection and reduce cystoscope damage (though this is a weak recommendation based on moderate evidence). 1
Common Pitfalls to Avoid
- Do not delay or cancel procedures solely based on asymptomatic positive urinalysis 3
- Do not routinely give antibiotics to low-risk patients with sterile urine - this contributes to antibiotic resistance without proven benefit 1, 4
- Do not perform cystoscopy during spinal shock following acute neurological events - wait until the condition stabilizes (typically 3-6 months, but can be up to 1-2 years) 1
- Do not skip hemodynamic monitoring in high-risk neurogenic bladder patients - autonomic dysreflexia can be life-threatening 1
Patient Subgroups at Higher Post-Procedure Infection Risk
Even without prophylaxis, certain groups have elevated UTI risk and warrant closer post-procedure monitoring: 3, 7
- Female patients (significantly higher risk on multivariate analysis) 7
- Diabetic patients (significantly higher risk on multivariate analysis) 7
- Patients with history of recurrent UTIs (OR 1.72) 3
- Patients found to have bladder tumors on cystoscopy (OR 2.22) 3
Note: Even in these higher-risk groups, prophylactic antibiotics have not been shown to significantly reduce infection rates 7.